D-1584-2014 Class III Terminated
FDA drug recall D-1584-2014 was initiated by Taro Pharmaceuticals U.S.A., Inc. on Aug 25, 2014 and is designated Class III. Reason for recall: Failed Content Uniformity Specifications. The recall status is terminated (terminated May 18, 2018). Affected quantity: 1396 Bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Sep 24, 2014
- Initiation Date
- Aug 25, 2014
- Termination Date
- May 18, 2018
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 1396 Bottles
Product description
Warfarin Sodium Tablets, USP Crystalline, 2 mg, 100 and 1000 Tablet Bottles, Rx Only. Mfd. by: Taro Pharmaceutical Industries, Ltd., Haifa Bay, Israel 26110. Dist. by: Taro Pharmaceuticals U.S.A., Inc., Hawthorne, NY 10532. 100 Tablet Bottle NDC: 51672-4028-1, 1000 Tablet Bottle NDC: 51672-4028-3.
Reason for recall
Failed Content Uniformity Specifications.
Distribution pattern
United States including: OH, HI, NH, MS, IL, TX, CA.
Code information
Lot #: 149400, Expiry: January 2016; Lot #: 149649, Expiry: January 2016.
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1584-2014
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026